Summary

Overview
The global antimicrobial coatings for medical devices market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031.
The use of medical devices has been increasing rapidly and they have become an integral part of modern medicine. Implantables, which are permanently fixed in the body, as well as single-use devices such as catheters, endotracheal tubes, and a variety of other consumables, are susceptible to several infections. These when medically used may pose a threat to the patients by interacting with their immune system causing prolongation of hospitalization or serious fatalities. Approximately 2% to 5% of the implants used in orthopedic surgery and nearly 14% of implants used in dental surgery are prone to infections.
The antibiotic coatings kill the bacteria and prevent the formation of biofilms, hence coating the medical devices is essential for preventing infection. There are several forms of medical device coatings with different purposes such as adhesion-resistant coatings, contact bactericidal coatings, release type-antibacterial coatings, multi-mechanism coatings, etc.
Market Dynamics: Drivers
Rising use of medical devices
As the population is on the rise, especially the geriatric demographic the demand for surgical procedures that are essential for treating age-related conditions is rising. The number of hospitalized patients, especially the elderly, are at a higher risk of hospital-acquired infections, specifically urinary tract infections. According to an article published in Springer Nature in November 2023, approximately 20% of hospitalized patients need urinary catheterization, during which the risk of infection is very high and approximately 40% of all hospital-acquired infections arise from urinary catheters.
In addition, several chronic conditions such as osteoarthritis, and cardiovascular problems that require surgical intervention in the form of implantable are also on the rise.
For instance, in March 2023, an epidemiological study published in the Journal of Bone and Joint Surgery stated that by 2040, the estimated number of total knee arthroplasty (TKA) surgeries is projected to be 1,222,988 and the number of total hip arthroplasty (THA) surgeries projected to be 719,364. The study has estimated that for every 5 years, the growth rate of THA and TKA surgical volumes would grow by 28.44% and 24.28%.
With the rise in orthopedic surgeries, the demand for sterile, pathogen-free, and resistant implants would increase drastically. The implants used for orthopedics stay permanently or for a long time inside the body, hence the risk of infection is also higher. The need for sterile implants is higher in these surgical procedures.
For instance, in May 2023, an article published in the National Center for Biotechnology Information stated that 5% of orthopedic implant surgery patients get infected due to the inserted implant and the cost of treating these infections is eight times higher than treating the fracture-related infections before the surgery.
Moreover, technological advances in antimicrobial coatings and the rising prevalence of hospital-acquired infections are expected to drive the market growth in the forecast period.
Restraints
Factors such as biocompatibility toxicity concerns and limited long-term efficacy are expected to restrain the market growth.
For more details on this report - Request for Sample
Segment Analysis
The global antimicrobial coatings for medical devices market is segmented based on type, device type and region.
The metal-based coatings in the type segment accounted for approximately 57.20% of the antimicrobial coatings for medical devices market share
Among the various types of antimicrobial coatings for medical devices, the most commonly employed ones are metal-based coatings. Metal ions and metal oxides, such as silver, are used in releasing-type bactericidal coatings. Silver kills various bacteria, has long-lasting antibacterial effects, and rarely causes resistance. It has been applied to orthopedic implants, with studies showing strong sterilization effects against S. aureus bacteria. In addition, zinc and copper are metal ions used in antibacterial coatings due to their ability to penetrate and destroy bacterial cell membranes.
Composite coatings loaded with Zn/Ag are proven to show excellent antimicrobial ability. Orthopedic surgeries are among the most widely performed procedures in the world. Surgical devices and implants play a crucial role in orthopedic surgery and metal-based coating has proven to provide long-term antimicrobial activity. These coatings release the ions slowly which is essential for the implants which are fixated for the long term inside the body. Moreover, these metal ions and oxides were explored a lot and are being developed in novel delivery techniques such as nanoparticles.
For instance, on December 10, 2022, an article published in ACS publication stated that metal ions and oxides have evolved as alternatives to polymer-loaded or surface-coated antibiotics on medical devices. The reason is that the prolonged exposure of pathogens to antibiotics may induce resistance in them. In recent times, research and development activities have risen which focus on creating nano-particle-based metallic coatings for medical devices.
On January 23, 2024, an article published in Springer Nature stated that silver is the most widely used metal for coating the surfaces of medical devices. The antimicrobial spectrum of silver is not limited, it has activity against all types of bacteria, viruses, and fungi. Moreover, the development of silver nanoparticles is easier even at large scale due to its availability, affordability, and bio-compatibility.
Geographical Analysis
North America accounted for approximately 45.6% of the market share
North America is dominating the antimicrobial coatings for medical devices market due to its huge healthcare industry. The major medical device manufacturers in the world have a strong hold market position in the region and generate most of their sales from this region. Moreover, the major countries in the region especially the U.S. and Canada have companies that offer various types of medical device coating services and those that hold the advanced coating technology. This concentration of industry leaders and innovative coating providers reinforces North America’s dominance in the global market.
For instance, the list below signifies the major market player in the medical device industry and their revenue share from the North America region.
Competitive Landscape
The major global players in the antimicrobial coatings for medical devices market include Microban Technologies., Specialty Coating Systems Inc., AST Products, Inc., DSM, Covalon.com., PPG Industries, Inc., jMedtech Coating Technologies Pte Ltd., CD Bioparticles., HeiQ Materials AG, BioInteractions. among others.
Market Segmentation
By Type
- Polymeric Coatings
- Hydrogels
- Polyethylene Glycol
- Poly Tetrafluoroethylene (PTFE)
- Zwitterionic Polymer
- Polysaccharides
- Others
- Metal-Based Coatings
- Titanium
- Silver
- Zinc
- Copper
- Magnesium
- Others
- Antibiotic Coatings
- Others
By Device Type
- Catheters & Tubes
- Urinary Catheters
- Central Venous Catheters
- Endotracheal Tubes
- Intravenous (IV) Catheters
- Others
- Surgical Implants and Instruments
- Orthopedic Implants
- Cardiac Implants
- Dental Implants
- Grafts
- Others
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Why Purchase the Report?
- To visualize the global antimicrobial coatings for medical devices market segmentation based on type, device type, and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of antimicrobial coatings for medical devices market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global antimicrobial coatings for medical devices market report would provide approximately 62 tables, 54 figures, and 187 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Device Type
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising use of medical devices
4.1.1.2. Rising prevalence of hospital-acquired infections
4.1.2. Restraints
4.1.2.1. Biocompatibility and toxicity concerns
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. Epidemiology Data
5.9. SWOT Analysis
6. By Test Kit Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Polymeric Coatings*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Hydrogels
6.2.4. Polyethylene Glycol
6.2.5. Poly Tetrafluoroethylene (PTFE)
6.2.6. Zwitterionic Polymer
6.2.7. Polysaccharides
6.2.8. Others
6.3. Metal-Based Coatings
6.3.1. Titanium
6.3.2. Silver
6.3.3. Zinc
6.3.4. Copper
6.3.5. Magnesium
6.3.6. Others
6.4. Antibiotic Coatings
6.5. Others
7. By Device Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
7.1.2. Market Attractiveness Index, By Device Type
7.2. Catheters & Tubes*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Urinary Catheters
7.2.4. Central Venous Catheters
7.2.5. Endotracheal Tubes
7.2.6. Intravenous (IV) Catheters
7.2.7. Others
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.5.1. The U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.5.1. Germany
8.3.5.2. UK
8.3.5.3. France
8.3.5.4. Italy
8.3.5.5. Spain
8.3.5.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.5.1. Brazil
8.4.5.2. Argentina
8.4.5.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.5.1. China
8.5.5.2. India
8.5.5.3. Japan
8.5.5.4. South Korea
8.5.5.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. Microban technologies.
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Financial Overview
10.1.4. Key Developments
10.2. Specialty Coating Systems Inc.
10.3. AST Products, Inc.
10.4. DSM
10.5. Covalon.com.
10.6. PPG Industries, Inc.
10.7. jMedtech Coating Technologies Pte Ltd.
10.8. CD Bioparticles.
10.9. HeiQ Materials AG
10.10. BioInteractions.
LIST NOT EXHAUSTIVE
11. Appendix
11.1. About Us and Services